• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: breast

  • Audio Journal of Oncology Volume 16 Number 11
    • in Oncology
    • — 3 Jun, 2008

    Audio Journal of Oncology Volume 16 Number 11

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)

    Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago

    Michael Gnant
    Michael Gnant

    In this edition:

    1. Zoledronic …

    Read more
    Audio Journal of Oncology Volume 16 Number 10
    • in Oncology
    • — 25 May, 2008

    Audio Journal of Oncology Volume 16 Number 10

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin

    In this edition Peter Goodwin and Sara Freeman report from:
    European Breast Cancer Conference, Berlin, April 15-19, 2008;
    Chemotherapy …

    Read more
  • Audio Journal of Oncology Volume 16 Number 9
    • in Oncology
    • — 26 Apr, 2008

    Audio Journal of Oncology Volume 16 Number 9

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

    Angel Rodriguez
    Angel Rodriguez

    In this edition:

    1. Lapatinib: Targets Breast Cancer Stem Cells?

    Angel Rodriguez, Baylor College, Houston…

    Read more
    Audio Journal of Oncology Volume 16 Number 8
    • in Oncology
    • — 15 Apr, 2008

    Audio Journal of Oncology Volume 16 Number 8

    Scientific Editors: George Canellos, Pat Price, Gordon McVie, Gianni Bonadonna

    In this edition:

    Bevacizumab and Survival in Metastatic Breast Cancer

    Source: N Engl J Med 357:26
    George Canellos, Dana-Farber Cancer Institute, Boston
    Progresson-free survival, but not overall survival, was …

    Read more
  • Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
    • in Oncology
    • — 1 Feb, 2008

    Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

    Cora Sternberg
    Cora Sternberg
    REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    CORA STERNBERG, San Camillo and Forlanini Hospital, Rome
    Satraplatin could provide a new option for patients with hormone refractory prostate cancer, by giving
    …
    Read more
    London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths
    • in Public Health
    • — 17 Jan, 2008

    London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths

    Zulfiqar Bhutta
    Zulfiqar Bhutta

    Reference: The Lancet, Maternal and Child Undernutrition Special Series
    With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta
    …
    Read more
  • Early Breast Cancer Chemotherapy: Long Term Findings
    • in News
    • — 8 Jan, 2008

    Early Breast Cancer Chemotherapy: Long Term Findings

    Richard Peto
    Richard Peto

    REFERENCE: Lancet 371:29-40; January 5, 2008
    RICHARD PETO, Oxford University
    The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He
    …
    Read more
    ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up
    • in Oncology
    • — 15 Dec, 2007

    ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up

    Jack Cuzick
    Jack Cuzick

    JACK CUZICK, Wolfson Institute of Preventive Medicine, London
    New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data
    …
    Read more
  • New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
    • in Oncology
    • — 15 Dec, 2007

    New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

    Jose Baselga
    Jose Baselga

    JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
    RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and
    …
    Read more
    Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
    • in Oncology
    • — 16 Nov, 2007

    Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

    Jean-Yves Douillard
    Jean-Yves Douillard
    Gordon McVie
    Gordon McVie

    REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    The vinca alkaloid vinflunine and
    …
    Read more
  • Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer
    • in Oncology
    • — 2 Nov, 2007

    Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer

    Nicholas James
    Nicholas James
    Gordon McVie
    Gordon McVie

    REFERENCE: Abstract: 3LB (Presidential Session), ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    NICHOLAS JAMES, Birmingham University
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    A new drug has improved overall survival
    …
    Read more
    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
    • in Oncology
    • — 16 Oct, 2007

    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

    Jose Baselga
    Jose Baselga
    Gordon McVie
    Gordon McVie

    REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    Neoadjuvant trastuzumab for patients with HER2-positive
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: breast

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.